Correlation Between Enorama Pharma and Enzymatica Publ
Can any of the company-specific risk be diversified away by investing in both Enorama Pharma and Enzymatica Publ at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enorama Pharma and Enzymatica Publ into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enorama Pharma AB and Enzymatica publ AB, you can compare the effects of market volatilities on Enorama Pharma and Enzymatica Publ and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enorama Pharma with a short position of Enzymatica Publ. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enorama Pharma and Enzymatica Publ.
Diversification Opportunities for Enorama Pharma and Enzymatica Publ
0.8 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Enorama and Enzymatica is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding Enorama Pharma AB and Enzymatica publ AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enzymatica publ AB and Enorama Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enorama Pharma AB are associated (or correlated) with Enzymatica Publ. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enzymatica publ AB has no effect on the direction of Enorama Pharma i.e., Enorama Pharma and Enzymatica Publ go up and down completely randomly.
Pair Corralation between Enorama Pharma and Enzymatica Publ
Assuming the 90 days trading horizon Enorama Pharma AB is expected to generate 1.46 times more return on investment than Enzymatica Publ. However, Enorama Pharma is 1.46 times more volatile than Enzymatica publ AB. It trades about 0.07 of its potential returns per unit of risk. Enzymatica publ AB is currently generating about -0.06 per unit of risk. If you would invest 235.00 in Enorama Pharma AB on September 1, 2024 and sell it today you would earn a total of 111.00 from holding Enorama Pharma AB or generate 47.23% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 100.0% |
Values | Daily Returns |
Enorama Pharma AB vs. Enzymatica publ AB
Performance |
Timeline |
Enorama Pharma AB |
Enzymatica publ AB |
Enorama Pharma and Enzymatica Publ Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Enorama Pharma and Enzymatica Publ
The main advantage of trading using opposite Enorama Pharma and Enzymatica Publ positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enorama Pharma position performs unexpectedly, Enzymatica Publ can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enzymatica Publ will offset losses from the drop in Enzymatica Publ's long position.Enorama Pharma vs. Kancera AB | Enorama Pharma vs. Cyxone AB | Enorama Pharma vs. Lidds AB | Enorama Pharma vs. Cantargia AB |
Enzymatica Publ vs. Oncopeptides AB | Enzymatica Publ vs. Diamyd Medical AB | Enzymatica Publ vs. Kancera AB | Enzymatica Publ vs. Bonesupport Holding AB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Complementary Tools
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |